Catherine Novack
Stock Analyst at Jones Trading
(0.47)
# 3,837
Out of 4,786 analysts
17
Total ratings
20%
Success rate
-19.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $27.99 | +60.77% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $1.33 | +727.07% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $17.41 | +646.70% | 1 | Nov 18, 2024 | |
| CAPR Capricor Therapeutics | Initiates: Buy | $40 | $9.49 | +321.50% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.39 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $8.08 | +98.02% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $2.15 | +551.16% | 1 | Sep 12, 2024 | |
| DARE Daré Bioscience | Maintains: Buy | $5 → $13 | $2.89 | +349.83% | 2 | Aug 16, 2024 | |
| RGLS Regulus Therapeutics | Initiates: Buy | $8 | $1.75 | +357.14% | 1 | May 31, 2024 | |
| RZLT Rezolute | Initiates: Buy | $10 | $2.90 | +244.83% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.25 | +700.00% | 1 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $1.91 | +1,051.83% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.88 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $2.66 | +5,915.04% | 1 | Jul 21, 2023 |
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $27.99
Upside: +60.77%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $1.33
Upside: +727.07%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $17.41
Upside: +646.70%
Capricor Therapeutics
Nov 18, 2024
Initiates: Buy
Price Target: $40
Current: $9.49
Upside: +321.50%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.39
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $8.08
Upside: +98.02%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $2.15
Upside: +551.16%
Daré Bioscience
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.89
Upside: +349.83%
Regulus Therapeutics
May 31, 2024
Initiates: Buy
Price Target: $8
Current: $1.75
Upside: +357.14%
Rezolute
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $2.90
Upside: +244.83%
Mar 20, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.25
Upside: +700.00%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $1.91
Upside: +1,051.83%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.88
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $2.66
Upside: +5,915.04%